Halozyme Therapeutics (HALO) Technical (Analysis) Reports Halozyme Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Halozyme Therapeutics (HALO)
Technical Analysis Report for USA stock HALO Halozyme Therapeutics. Dated: 05 Dec 2025 Updated Daily. Stock trades under Health Care Deals in Biotechnology Biological Products No Diagnostic Substances in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock HALO Halozyme Therapeutics then click here. or read Experts views on Halozyme Therapeutics or Forecast & share price targets of Halozyme Therapeutics
Halozyme Therapeutics Opened at 62.81 and Closed at: 63.33, which is 0.68% of previous session's close. It moved within a range of 62.59 and 63.98
The session was a Bullish session with an average volume of 1550600, which is -57.04% of previous session's volumes.
- Even though the stock has shown an up move, but the short term trend of the stock remains negative and in a downtrend.
- Even though the stock has shown an up move, but the mid term trend of the stock remains negative and in a downtrend.
- The stock has shown an up move, and its long term trend is also positive and in an uptrend.
A Dead cross was found 2 days back on short term averages
Support for tomorrow is 62.96 and resistance for tomorrow is 64.35
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 62.62, 61.91 resistance for tomorrow's hourly charts is 64.01, 64.69
10 Day SMA for Halozyme Therapeutics (HALO) is 68.68 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Halozyme Therapeutics (HALO) is 69.24 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Halozyme Therapeutics (HALO) is 68.18 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 68.39 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Halozyme Therapeutics is 63.13 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Halozyme Therapeutics is at 69.24 and 200 DMA is at 63.13, while 50 DMA and 100 DMA are at 68.18 and 68.39 respectively
Halozyme Therapeutics (HALO) moving average of 20 SMA is at 69.24 and 20 EMA is at 68.1
| Date | Closing Price | 20 SMA | 20 EMA |
| 05 Fri Dec | 63.33 | 69.24 | 68.1 |
| 04 Thu Dec | 62.90 | 69.5 | 68.6 |
| 03 Wed Dec | 64.66 | 69.77 | 69.2 |
| 02 Tue Dec | 66.54 | 69.94 | 69.68 |
| 01 Mon Dec | 68.10 | 69.87 | 70.01 |
| 28 Fri Nov | 71.40 | 69.72 | 70.21 |
Halozyme Therapeutics (HALO) moving average of 50 SMA is at 68.18 and 50 EMA is at 68.45
| Date | Closing Price | 50 SMA | 50 EMA |
| 05 Fri Dec | 63.33 | 68.18 | 68.45 |
| 04 Thu Dec | 62.90 | 68.39 | 68.66 |
| 03 Wed Dec | 64.66 | 68.65 | 68.9 |
| 02 Tue Dec | 66.54 | 68.91 | 69.07 |
| 01 Mon Dec | 68.10 | 69.14 | 69.17 |
| 28 Fri Nov | 71.40 | 69.33 | 69.21 |
Halozyme Therapeutics (HALO) moving average of 100 SMA is at 68.39 and 100 EMA is at 67.1
| Date | Closing Price | 100 SMA | 100 EMA |
| 05 Fri Dec | 63.33 | 68.39 | 67.1 |
| 04 Thu Dec | 62.90 | 68.33 | 67.18 |
| 03 Wed Dec | 64.66 | 68.27 | 67.27 |
| 02 Tue Dec | 66.54 | 68.2 | 67.32 |
| 01 Mon Dec | 68.10 | 68.11 | 67.34 |
| 28 Fri Nov | 71.40 | 68 | 67.32 |
Halozyme Therapeutics (HALO) moving average of 200 SMA is at 63.13 and 200 EMA is at 63.92
| Date | Closing Price | 200 SMA | 200 EMA |
| 05 Fri Dec | 63.33 | 63.13 | 63.92 |
| 04 Thu Dec | 62.90 | 63.1 | 63.93 |
| 03 Wed Dec | 64.66 | 63.07 | 63.94 |
| 02 Tue Dec | 66.54 | 63.04 | 63.93 |
| 01 Mon Dec | 68.10 | 63 | 63.9 |
| 28 Fri Nov | 71.40 | 62.95 | 63.86 |
U S has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in U S, about 8.77% more returns!
Stryker Corporation has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Stryker Corporation, about 9.44% more returns!
Halozyme Therapeutics has performed better than Conmed Corporation in short term. Holding Halozyme Therapeutics could be a better choice for now!
Centene Corporation has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Centene Corporation, about 9.28% more returns!
Halozyme Therapeutics has performed better than Concord Medical in short term. Holding Halozyme Therapeutics could be a better choice for now!
Verastem Inc has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Verastem Inc, about 35.74% more returns!
Trinity Biotech has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Trinity Biotech, about 8.25% more returns!
Tiziana Life has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Tiziana Life, about 6.63% more returns!
China Sxt has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in China Sxt, about 10.12% more returns!
Novocure has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Novocure, about 18.1% more returns!
Madrigal Pharmaceuticals has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Madrigal Pharmaceuticals, about 25.19% more returns!
Moleculin Biotech has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Moleculin Biotech, about 1384.75% more returns!
Healthcare Services has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Healthcare Services, about 16.59% more returns!
Fennec Pharmaceuticals has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Fennec Pharmaceuticals, about 1.81% more returns!
Cytomx Therapeutics has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Cytomx Therapeutics, about 16.02% more returns!
Cumberland Pharmaceuticals has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Cumberland Pharmaceuticals, about 19.41% more returns!
Aurinia Pharmaceuticals has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Aurinia Pharmaceuticals, about 14.11% more returns!
Alnylam Pharmaceuticals has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Alnylam Pharmaceuticals, about 10.68% more returns!
Halozyme Therapeutics has performed better than Akari Therapeutics in short term. Holding Halozyme Therapeutics could be a better choice for now!
Halozyme Therapeutics Technical analysis of indicators
Price action analysis of Halozyme Therapeutics (HALO) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Halozyme Therapeutics stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Halozyme Therapeutics in short term and the sell signal is strong.
Halozyme Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a SELL signal for Halozyme Therapeutics in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Halozyme Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 69.23 and Halozyme Therapeutics HALO stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Halozyme Therapeutics HALO stock. Volume based technical analysis of Halozyme Therapeutics HALO stock is negative.
Halozyme Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock HALO Halozyme Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And HALO Experts View which covers a lot of information including buying and selling signals
HALO future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Halozyme Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Halozyme Therapeutics (HALO) Technical (Analysis) Reports Halozyme Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance


